ImageneBio Income Statement (2020-2025) | IMA

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
3.47M3.55M3.75M20.22M3.38M0.38M6.40M5.45M5.31M2.00M1.19M0.66M3.50M0.80M
Operating items
Research & Development (Quarter)
10.02M11.37M13.38M12.34M14.34M15.49M18.85M15.64M15.55M15.17M14.65M14.27M14.00M9.83M3.88M2.52M4.04M4.03M15.56M
Wages, Salaries and Other (Quarter)
0.57M1.05M
Selling, General & Administrative (Quarter)
3.17M4.86M4.89M5.09M6.00M5.84M5.43M4.92M5.28M5.32M6.03M8.29M6.00M5.31M1.65M17.67M2.75M4.42M11.04M
Restructuring Costs (Quarter)
1.90M0.68M0.41M-0.54M1.44M0.31M2.85M
Other Operating Expenses (Quarter)
-3.67M-0.41M4.96M-1.44M-2.85M
Operating Expenses (Quarter)
13.19M16.24M18.27M17.43M20.35M21.33M24.28M20.56M20.83M20.49M20.69M22.57M18.23M15.82M5.54M24.61M6.79M8.75M26.59M
Operating Income (Quarter)
-9.72M-12.69M-14.52M2.79M-16.96M-20.95M-17.88M-15.11M-15.52M-18.49M-19.50M-21.91M-18.23M-15.82M-2.04M-28.11M-6.00M-8.75M-26.59M
EBIT (Quarter)
-9.72M-12.69M-14.52M2.79M-16.96M-20.95M-17.88M-15.11M-15.52M-18.49M-19.50M-21.91M-18.23M-15.82M-2.04M-28.11M-6.00M-8.75M-26.59M
Non-operating items
Interest & Investment Income (Quarter)
0.01M0.01M0.01M0.17M0.46M0.55M1.01M1.30M1.38M2.16M2.27M2.11M1.92M0.05M7.03M-0.08M1.29M-0.10M
Other Non Operating Income (Quarter)
0.00M0.01M0.01M0.01M-0.05M0.46M0.54M1.02M0.57M-0.01M-0.00M-0.01M-0.01M0.23M-1.19M3.76M-0.01M4.71M1.84M
Non Operating Income (Quarter)
0.00M0.01M0.01M0.01M-0.05M0.46M0.54M1.02M1.30M-0.01M-0.00M-4.85M2.11M0.23M-1.19M10.79M-0.08M4.71M1.84M
Net income details
EBT (Quarter)
-9.72M-12.68M-14.52M2.80M-16.84M-20.54M-17.34M-14.10M-14.22M-17.11M-17.34M-19.65M-16.12M-13.67M-3.18M-17.33M-6.08M-2.75M-24.85M
Tax Provisions (Quarter)
0.03M0.06M0.15M0.03M0.01M-0.07M
Profit After Tax (Quarter)
-9.72M-12.68M-14.52M2.80M-16.84M-20.49M-17.34M-14.10M-14.22M-17.11M-17.34M-19.49M-22.31M-6.26M-3.18M-17.44M-6.08M-7.58M-24.78M
Income from Continuing Operations (Quarter)
-9.72M-12.68M-14.52M2.80M-16.84M-20.54M-17.34M-14.10M-14.22M-17.11M-17.34M-19.65M-16.15M-13.73M-3.18M-17.48M-6.11M-2.77M-24.78M
Consolidated Net Income (Quarter)
-9.72M-12.68M-14.52M2.80M-16.84M-20.54M-17.34M-14.10M-14.22M-17.11M-17.34M-19.65M-16.15M-13.73M-3.18M-17.48M-6.11M-2.77M-24.78M
Income towards Parent Company (Quarter)
-9.72M-12.68M-14.52M2.80M-16.84M-20.54M-17.34M-14.10M-14.22M-17.11M-17.34M-19.65M-16.15M-13.73M-3.18M-17.48M-6.11M-2.77M-24.78M
Preferred Dividend Payments (Quarter)
3.00M3.05M0.85M
Net Income towards Common Stockholders (Quarter)
-9.72M-12.68M-14.52M2.80M-16.84M-20.54M-17.34M-14.10M-14.22M-17.11M-17.34M-19.65M-16.15M-13.73M-6.18M-17.48M-9.13M-2.77M-25.62M
Additional items
EPS (Basic) (Quarter)
-2.52-0.35-0.400.24-0.47-0.57-0.48-0.39-0.39-0.44-0.40-0.40-0.33-0.28-2.5818.12-3.80-0.06-2.91
EPS (Weighted Average and Diluted) (Quarter)
-0.35-0.400.10-0.47-0.57-0.48-0.39-0.39-0.44-0.40-0.40-0.33-0.28-2.5818.12-3.80-0.06-2.91
Shares Outstanding (Weighted Average) (Quarter)
3.85M19.94M35.86M27.98M36.08M36.12M36.26M36.19M36.26M37.78M43.44M41.74M48.26M48.26M1.12M48.26M1.41M48.26M8.53M0.53M
Shares Outstanding (Diluted Average) (Quarter)
19.94M25.31M27.98M36.08M36.12M36.17M36.19M36.26M39.29M39.69M41.74M48.26M48.26M0.99M48.26M2.40M48.26M3.81M
EBITDA (Quarter)
-9.72M-12.69M-14.52M2.79M-16.96M-20.95M-17.88M-15.11M-15.52M-18.49M-19.50M-21.91M-18.23M-15.82M-2.04M-28.11M-6.00M-8.75M-26.59M
Interest Expenses (Quarter)
0.05M0.05M0.01M-0.00M0.01M0.00M0.01M
Shares Outstanding (Quarter)
35.85M35.86M35.88M35.98M36.11M36.25M36.26M36.26M36.26M42.30M44.10M0.98M0.99M0.98M1.41M1.41M0.99M1.41M11.18M11.18M
Tax Rate (Quarter)
-0.17-0.45-0.88-0.46-0.550.30